Skip to content

Author

Klaus Okkenhaug

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Atypical T cell receptor signalling permits distinct gut γδ T cell responses to healthy versus dysregulated tissues

Intraepithelial lymphocytes (IEL) are conserved across vertebrates and commonly enriched in γδ T cells. Several such γδ IELs depend upon homeostatic interactions of their T cell receptors (TCRs) with butyrophilin-like (BTNL) proteins expressed by healthy enterocytes and colonocytes. What limits such interactions from i...

L. Monin, Florencia Cano, J. Axford et al. · 0 citations
Sep 2026

Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species.

Reactive oxygen species (ROS) promote genomic instability and fuel oncogenic signaling in cancer, but antioxidant therapies have so far failed to improve, or worsen, cancer outcomes. Emerging data suggest that T cells depend on ROS for signal transduction. In this study, we show that tumors exploit this dependency, rel...

Alexander J. Wesolowski, Ardon M. Pillay, Panagiota Vardaka et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.